About the Program
While approximately 35 million Americans carry a penicillin allergy label, nearly 90% do not have a true allergy. Having a documented penicillin allergy leads to more negative health care outcomes including higher rates of adverse drug events, greater infection risks with resistant organisms, and higher overall health care costs.
Our Penicillin Allergy Assessment & Skin Testing Certificate (PAAST) program is designed to hone skills of health care providers in allergy assessment and penicillin skin testing for the purpose of improving antibiotic selection and patient outcomes following allergy reconciliation. At the conclusion, all participants completing the online material and live program portions will receive an official certificate documenting their competency.
Whether you’re a trainee or seasoned practitioner, any health care provider involved in antibiotic administration, prescribing, and/or decision-making including nurses, pharmacists, nurse practitioners, physician assistants, and physicians, you'll find value in this program.
CE Accredited Program
This 15-hour continuing education accredited program combines interactive and in-depth home study with live programming offered at host sites across the country.
Program advisory board members and content authors are among the nation’s leading physician and pharmacist experts and scholars in penicillin allergy related outcomes and execution of comprehensive allergy assessment and skin testing.
The University of South Carolina is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a practice-based activity which is accredited for a total of 15 contact hours (1.5 CEUs) for pharmacists (UAN 0062-9999-19-002-B01-P). Initial release date: January 5, 2019; expiration date: January 5, 2022. In order to complete this practice-based program, all pharmacists are required to view all home study modules in their entirety (participating in active learning components as prompted), pass the home study post-test (prior to attending the live session), and attend a live session in its entirety. No partial credit will be awarded. Credit will not be awarded for completing only the home study modules if a live session is not attended, and credit will not be awarded for completing only the live session if the home study modules are not completed and the post-test is not passed. In order to have credit reported to the NABP CPE Monitor, participants must complete the online program evaluations within 30 days of the live activity and must provide their correct NABP e-profile number and day/month of birth. Any credit claimed greater than 60 days from the date of the live activity will be automatically rejected by the NABP CPE Monitor.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical University of South Carolina and the University of South Carolina College of Pharmacy. The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians
The Medical University of South Carolina designates the live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. The Medical University of South Carolina designates the enduring activity for a maximum of 11 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mid-Carolina AHEC, Inc. is an approved provider of continuing nursing education by the South Carolina Nurse Association, an accredited approver with distinction, by the American Nurses Credentialing Center’s Commission on Accreditation. This nursing continuing education activity approval #1811-032PR-011 has been approved for 15.0 hours.
PAAST Program Goals
At the conclusion of the program, the participant will be able to:
- Evaluate antibiotic-associated allergies and the negative outcomes associated with documented beta-lactam allergies.
- Recommend appropriate first- and second-line therapies for common disease states that include beta-lactam antibiotics as a preferred therapy.
- Describe methods for successfully and safely optimizing antibiotic therapy in a patient with a documented penicillin allergy.
- Perform a comprehensive allergy assessment and assess the need for penicillin skin testing.
- Execute and interpret the results a penicillin allergy skin test.
- Implement a comprehensive allergy assessment and skin testing program at your institution.
This program is supported by a generous unrestricted educational grant from ALK-Abello, Inc.